could semaglutide Can Help With Alcohol Cravings? Semaglutide: Double-edged Sword with Risks
Description
In 2024, the FDA approved Zepbound as the first GLP-1 medication specifically indicated to treat obstructive sleep apnea (OSA) in adults with obesity
Accessed February 20, 2025
USC Schaeffer
95% CI 0.67 0.95) in the confirmatory secondary outcomes, in addition to the reduced risk of the primary outcome events (HR 0.76
)
